Bioquell Limited Sustainability Profile
Bioquell Limited, headquartered in Great Britain, is a leading provider of innovative bio-decontamination solutions. Founded in 1997, the company has established itself within the healthcare and pharmaceutical industries, focusing on infection control and environmental decontamination. Bioquell's core offerings include its unique hydrogen peroxide vapour technology, which effectively eliminates harmful pathogens in critical environments. This advanced method sets Bioquell apart, ensuring compliance with stringent regulatory standards and enhancing patient safety. With a strong presence in Europe and expanding operations globally, Bioquell has achieved significant milestones, including partnerships with major healthcare institutions. The company is recognised for its commitment to quality and innovation, solidifying its position as a trusted leader in bio-decontamination solutions.
DitchCarbon Score
How does Bioquell Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bioquell Limited's score of 91 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bioquell Limited, headquartered in Great Britain, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Ecolab Inc., and any climate commitments or emissions data may be influenced by initiatives from its parent organization. As part of its corporate family relationship with Ecolab Inc., Bioquell Limited may align with the sustainability and climate strategies set forth by Ecolab, which includes various reduction initiatives. However, specific reduction targets or achievements for Bioquell Limited are not detailed in the available information. Bioquell Limited's climate commitments may be informed by Ecolab's broader sustainability goals, including participation in initiatives such as the Science Based Targets initiative (SBTi) and the CDP. These initiatives aim to drive significant reductions in greenhouse gas emissions across their operations. In summary, while Bioquell Limited does not currently report specific emissions data or reduction targets, it is positioned within a corporate structure that prioritises sustainability and climate action through its relationship with Ecolab Inc.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 396,916,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 289,712,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 6,919,965,000 | 0,000,000,000 | 0,000,000,000 | - | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Bioquell Limited's Industry?
How Carbon Intensive is Bioquell Limited's Location?
Bioquell Limited's Scope 3 Categories Breakdown
Bioquell Limited's Scope 3 emissions, which increased by 12% last year and increased by approximately 13% since 2015, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 66% of Scope 3 emissions.
Top Scope 3 Categories
Bioquell Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bioquell Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
